Details for Patent: 9,006,224

Which drugs does patent 9,006,224 protect, and when does it expire?

Patent 9,006,224 protects AFINITOR and is included in one NDA.

This patent has forty-eight patent family members in twenty-four countries.

Summary for Patent: 9,006,224

Patent landscape, scope, and claims:

Title:	Neuroendocrine tumor treatment
Abstract:	A method for treating endocrine tumors by administration of an mTOR inhibitor, optionally in combination with another drug.
Inventor(s):	Marks; Peter Wayne (Woodbridge, CT), Lebwohl; David (Madison, NJ)
Assignee:	Novartis AG (Basel, CH)
Application Number:	12/094,173
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,006,224
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 9,006,224

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-003	Jul 9, 2010	AB	RX	Yes	No	9,006,224					TREATMENT OF PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-001	Mar 30, 2009	AB	RX	Yes	Yes	9,006,224					TREATMENT OF PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-004	Mar 30, 2012	AB	RX	Yes	No	9,006,224					TREATMENT OF PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC
Novartis	AFINITOR	everolimus	TABLET;ORAL	022334-002	Mar 30, 2009	AB	RX	Yes	No	9,006,224					TREATMENT OF PATIENTS WITH PROGRESSIVE NEUROENDOCRINE TUMORS OF PANCREATIC ORIGIN (PNET) THAT ARE UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC

Foreign Priority and PCT Information for Patent: 9,006,224

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0523658.3	Nov 21, 2005
United Kingdom	0601082.1	Jan 19, 2006
United Kingdom	0602747.8	Feb 10, 2006
United Kingdom	0607942.0	Apr 21, 2006

PCT Information
PCT Filed	November 20, 2006	PCT Application Number:	PCT/EP2006/068656
PCT Publication Date:	May 24, 2007	PCT Publication Number:	WO2007/057457

International Family Members for US Patent 9,006,224

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006314444
Australia	2010202866
Brazil	PI0618808
Canada	2629245